Locust Wood Capital Advisers’s Elevance Health ELV Stock Holding History

Locust Wood Capital Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-78,300	Closed	-$30.5M	–	58
2025 Q2	$30.5M	Hold	78,300	–	–	0.81%	29
2025 Q1	$34.1M	Sell	78,300 -25,500	-25%	-$10.2M	1.08%	27
2024 Q4	$38.3M	Buy	+103,800	New	+$43.4M	1.32%	27
2022 Q2	–	Sell	-11,900	Closed	-$5.85M	–	50
2022 Q1	$5.85M	Sell	11,900 -73,600	-86%	-$33.6M	0.32%	37
2021 Q4	$39.6M	Buy	85,500 +11,900	+16%	+$5.01M	1.98%	24
2021 Q3	$27.4M	Hold	73,600	–	–	1.49%	29
2021 Q2	$28.1M	Sell	73,600 -2,600	-3%	-$994K	1.62%	26
2021 Q1	$27.4M	Sell	76,200 -9,100	-11%	-$2.93M	1.61%	27
2020 Q4	$27.4M	Hold	85,300	–	–	1.56%	27
2020 Q3	$22.9M	Buy	85,300 +8,500	+11%	+$2.29M	1.48%	27
2020 Q2	$20.2M	Buy	76,800 +10,800	+16%	+$2.88M	1.25%	27
2020 Q1	$15M	Buy	66,000 +2,000	+3%	+$545K	1.27%	27
2019 Q4	$19.3M	Hold	64,000	–	–	1.43%	31
2019 Q3	$15.4M	Hold	64,000	–	–	1.3%	29
2019 Q2	$18.1M	Buy	64,000 +53,400	+504%	+$14.6M	1.33%	29
2019 Q1	$3.04M	Buy	+10,600	New	+$3.07M	0.24%	41

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Locust Wood Capital Advisers's ELV Position: Q1 2026 in Review

Locust Wood Capital Advisers sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 142,053 shares — an estimated $49.8M sold.

Locust Wood Capital Advisers first reported a position in ELV in Q3 2018 and held it in 30 quarters. The position peaked at $162M in Q2 2024. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Locust Wood Capital Advisers reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
Locust Wood Capital Advisers sold 142,053 Elevance Health shares in Q1 2026, an estimated $49.8M.
Locust Wood Capital Advisers first reported a position in Elevance Health in Q3 2018 and held it in 30 quarters.
Locust Wood Capital Advisers's Elevance Health position peaked at $162M in Q2 2024.
1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Locust Wood Capital Advisers's 13F filing for Q1 2026, filed 11 May 2026.